| 前收市價 | 0.1500 |
| 開市 | 0.1500 |
| 買盤 | 0.0000 |
| 賣出價 | 0.2000 |
| 拍板 | 2.50 |
| 到期日 | 2024-06-21 |
| 今日波幅 | 0.1000 - 0.1500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 894 |
ZacksAtara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 37.84% and 1.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksAtara Biotherapeutics (ATRA) Reports Q4 Loss, Tops Revenue Estimates
Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of 8.20% and 73.91%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insider MonkeyBillionaire Seth Klarman’s Biotech Stock Picks
In this article, we discuss billionaire Seth Klarman’s biotech stock picks. To skip the detailed analysis of the biotech industry, Seth Klarman’s investment philosophy, and Baupost Group’s performance and Q3 bets, go directly to Billionaire Seth Klarman’s Top 4 Biotech Stock Picks. Biotechnology is the technology segment that utilizes cellular and biomolecular processes for the […]
